SecSonar.com

Curis, Inc. (CRIS)

Curis, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Curis, Inc. (CRIS) is a Biotechnology company based in US with a market capitalization of $7M. Revenue declined 13.4% year-over-year and free cash flow was negative at -$27.2M. This page tracks CRIS's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 34 employees · IPO Aug 1, 2000

Valuation

Valuation & price

$0.49 · as of May 17, 2026 · -74.6% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

1.29

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$1.84$1.08$0.32Jul 25Dec 25Jul 26Jul 7, 25$1.74Jul 9, 25$1.83Jul 11, 25$1.83Jul 15, 25$1.84Jul 17, 25$1.84Jul 21, 25$1.74Jul 23, 25$1.82Jul 25, 25$1.84Jul 29, 25$1.76Jul 31, 25$1.66Aug 4, 25$1.60Aug 6, 25$1.67Aug 11, 25$1.63Aug 13, 25$1.72Aug 15, 25$1.83Aug 19, 25$1.60Aug 21, 25$1.56Aug 25, 25$1.65Aug 27, 25$1.63Aug 29, 25$1.67Sep 3, 25$1.72Sep 5, 25$1.68Sep 9, 25$1.81Sep 11, 25$1.82Sep 16, 25$1.71Sep 18, 25$1.72Sep 22, 25$1.68Sep 24, 25$1.69Sep 26, 25$1.69Sep 30, 25$1.66Oct 2, 25$1.61Oct 6, 25$1.66Oct 8, 25$1.62Oct 10, 25$1.52Oct 14, 25$1.54Oct 16, 25$1.56Oct 21, 25$1.58Oct 23, 25$1.63Oct 27, 25$1.56Oct 29, 25$1.50Oct 31, 25$1.49Nov 4, 25$1.46Nov 6, 25$1.46Nov 10, 25$1.31Nov 12, 25$1.23Nov 14, 25$1.33Nov 18, 25$1.23Nov 20, 25$1.08Nov 25, 25$1.13Nov 28, 25$1.37Dec 2, 25$1.20Dec 4, 25$1.35Dec 8, 25$1.35Dec 10, 25$1.30Dec 12, 25$1.16Dec 16, 25$1.18Dec 18, 25$1.15Dec 22, 25$1.03Dec 24, 25$1.05Dec 29, 25$1.04Jan 2, 26$0.98Jan 6, 26$1.00Jan 8, 26$0.85Jan 12, 26$0.92Jan 14, 26$0.90Jan 16, 26$1.00Jan 21, 26$0.90Jan 23, 26$0.94Jan 27, 26$0.95Jan 29, 26$0.91Feb 2, 26$0.87Feb 4, 26$0.95Feb 9, 26$0.97Feb 11, 26$1.06Feb 13, 26$1.15Feb 18, 26$1.08Feb 20, 26$1.11Feb 24, 26$1.08Feb 26, 26$1.11Mar 2, 26$1.08Mar 4, 26$1.03Mar 6, 26$0.99Mar 10, 26$1.01Mar 12, 26$1.01Mar 17, 26$0.89Mar 19, 26$0.76Mar 23, 26$0.74Mar 25, 26$0.70Mar 27, 26$0.56Mar 31, 26$0.55Apr 2, 26$0.55Apr 7, 26$0.55Apr 9, 26$0.51Apr 13, 26$0.62Apr 15, 26$0.68Apr 17, 26$0.60Apr 22, 26$0.61Apr 24, 26$0.60Apr 28, 26$0.58Apr 30, 26$0.60May 4, 26$0.58May 6, 26$0.62May 8, 26$0.56May 12, 26$0.55May 14, 26$0.51May 18, 26$0.48May 20, 26$0.50May 22, 26$0.50May 28, 26$0.52Jun 1, 26$0.52Jun 3, 26$0.50Jun 5, 26$0.47Jun 9, 26$0.45Jun 11, 26$0.43Jun 15, 26$0.42Jun 17, 26$0.41Jun 22, 26$0.43Jun 24, 26$0.34Jun 26, 26$0.32Jul 2, 26$0.35
$0.2152-week range$1.93
Loading valuation history…

Fundamentals

Key fundamentals

$7M

Market cap

-13.4%

Revenue growth (YoY)

99.5%

Gross margin

-$27.2M

Free cash flow (USD)

-$3.4M

Net debt

Net cash position

1987.5%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$7.5MFY 2017$9.9MFY 2018$10.4MFY 2019$10.0MFY 2020$10.8MFY 2021$10.6MFY 2022$10.2MFY 2023$10.0MFY 2024$10.9MFY 2025$9.4M
$7.5M$9.4M

Free cash flow by year

2016 → 2025

FY 2016$-36.1MFY 2017$-48.5MFY 2018$-30.1MFY 2019$-26.2MFY 2020$-26.4MFY 2021$-37.6MFY 2022$-54.8MFY 2023$-38.4MFY 2024$-39.6MFY 2025$-27.2M
-$36.1M-$27.2M

Gross margin by year

2021 → 2025

FY 202195.0%FY 202297.5%FY 202397.9%FY 202499.1%FY 202599.5%
95.0%99.5%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed May 13, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventReverse Stock SplitJul 2, 2026Filing
  • 8-K eventReverse Stock SplitJul 1, 2026Filing
  • 8-K eventReverse Stock SplitJul 1, 2026Filing
  • 8-K eventStockholder Meeting ResultsJun 25, 2026Filing
  • 8-K eventShare Authorization IncreaseMay 22, 2026Filing
  • Quarterly report10-Q FiledMay 13, 2026Filing
  • 8-K eventEarnings ReleaseMay 12, 2026Filing
  • 8-K eventDelisting NoticeMay 1, 2026Filing
  • Insider buyInsider Buy $5KKAITIN KENNETH I · Director · $5.5KApr 1, 2026Filing

Questions

Frequently asked questions

What is Curis, Inc.'s market cap?

Curis, Inc. (CRIS) has a market capitalization of $7M.

What is CRIS's P/E ratio?

A meaningful P/E ratio is not available for CRIS — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is CRIS's price-to-book (P/B) ratio?

CRIS trades at 1.29 times book value per share.

Are insiders buying CRIS stock?

SEC Form 4 filings show no open-market insider buys at Curis, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

CUPR

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares

$6.7M

TCRT

Alaunos Therapeutics, Inc.

$7.4M

SYBX

Synlogic, Inc.

$7.8M

APRE

Aprea Therapeutics, Inc.

$6.1M

EVGN

Evogene Ltd.

$6.1M

XBIO

Xenetic Biosciences, Inc.

$5.9M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.